Publication | Closed Access
Dehydroepiandrosterone Sulfate in a Long-term Care Aged Population
81
Citations
0
References
1995
Year
AgingGeriatric MedicineMetabolic SyndromeAlzheimer's DiseaseLongevityDehydroepiandrosterone SulfateNeurologyAging-associated DiseaseSteroid MetabolismHealth SciencesDheas LevelsSerum Dehydroepiandrosterone SulfateNinety-four Institutionalized SubjectsGeriatricsVascular DementiaPharmacologyRisk FactorsVascular Cognitive DisorderDementiaMenopauseMedicine
Ninety-four institutionalized subjects (mean age 82.9 years; 13 men and 81 women) were assessed for serum dehydroepiandrosterone sulfate (DHEAS) levels. The mean value was 457 ng/ml (SD = 426) in this cross-sectional study. There was a significant decrease in DHEAS levels with age. There was no difference among demented patients with Alzheimer's disease (n = 46), other dementia cases (n = 16), and other individuals (n = 32). The subjects treated for arterial hypertension had significantly lower DHEAS levels. No correlation was found between DHEAS and cortisol values. After age adjustment, no association was observed between DHEAS and chronic diseases, medications, several biochemical or hematological parameters, or 3-year mortality.